These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7604143)

  • 1. Progesterone co-administration in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal severity and taper outcome.
    Schweizer E; Case WG; Garcia-Espana F; Greenblatt DJ; Rickels K
    Psychopharmacology (Berl); 1995 Feb; 117(4):424-9. PubMed ID: 7604143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.
    Rickels K; DeMartinis N; García-España F; Greenblatt DJ; Mandos LA; Rynn M
    Am J Psychiatry; 2000 Dec; 157(12):1973-9. PubMed ID: 11097963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trazodone and valproate in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal symptoms and taper outcome.
    Rickels K; Schweizer E; Garcia España F; Case G; DeMartinis N; Greenblatt D
    Psychopharmacology (Berl); 1999 Jan; 141(1):1-5. PubMed ID: 9952057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial.
    Hadley SJ; Mandel FS; Schweizer E
    J Psychopharmacol; 2012 Apr; 26(4):461-70. PubMed ID: 21693549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation.
    Rickels K; Schweizer E; Case WG; Greenblatt DJ
    Arch Gen Psychiatry; 1990 Oct; 47(10):899-907. PubMed ID: 2222129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbamazepine treatment in patients discontinuing long-term benzodiazepine therapy. Effects on withdrawal severity and outcome.
    Schweizer E; Rickels K; Case WG; Greenblatt DJ
    Arch Gen Psychiatry; 1991 May; 48(5):448-52. PubMed ID: 2021297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prior benzodiazepine exposure and benzodiazepine treatment outcome.
    Rickels K; Freeman EW
    J Clin Psychiatry; 2000 Jun; 61(6):409-13. PubMed ID: 10901337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term benzodiazepine users 3 years after participation in a discontinuation program.
    Rickels K; Case WG; Schweizer E; Garcia-Espana F; Fridman R
    Am J Psychiatry; 1991 Jun; 148(6):757-61. PubMed ID: 2035717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregabalin long-term treatment and assessment of discontinuation in patients with generalized anxiety disorder.
    Kasper S; Iglesias-García C; Schweizer E; Wilson J; DuBrava S; Prieto R; Pitman VW; Knapp L
    Int J Neuropsychopharmacol; 2014 May; 17(5):685-95. PubMed ID: 24351233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of captodiamine in the withdrawal from long-term benzodiazepine treatment.
    Mercier-Guyon C; Chabannes JP; Saviuc P
    Curr Med Res Opin; 2004 Sep; 20(9):1347-55. PubMed ID: 15383182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Withdrawal reaction after long-term therapeutic use of benzodiazepines.
    Busto U; Sellers EM; Naranjo CA; Cappell H; Sanchez-Craig M; Sykora K
    N Engl J Med; 1986 Oct; 315(14):854-9. PubMed ID: 3092053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.
    Small GW; Bystritsky A
    J Clin Psychiatry; 1997; 58 Suppl 11():24-9. PubMed ID: 9363045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurosteroid coadministration prevents development of tolerance and augments recovery from benzodiazepine withdrawal anxiety and hyperactivity in mice.
    Reddy DS; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1997; 19(6):395-405. PubMed ID: 9385589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment.
    Fontaine R; Chouinard G; Annable L
    Am J Psychiatry; 1984 Jul; 141(7):848-52. PubMed ID: 6145363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
    Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
    J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term therapeutic use of benzodiazepines. II. Effects of gradual taper.
    Schweizer E; Rickels K; Case WG; Greenblatt DJ
    Arch Gen Psychiatry; 1990 Oct; 47(10):908-15. PubMed ID: 2222130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychomotor performance of long-term benzodiazepine users before, during, and after benzodiazepine discontinuation.
    Rickels K; Lucki I; Schweizer E; García-España F; Case WG
    J Clin Psychopharmacol; 1999 Apr; 19(2):107-13. PubMed ID: 10211911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy and withdrawal of clobazam, lorazepam and buspirone in the treatment of anxiety disorders].
    Lemoine P; Rouillon F; Pouget D
    Encephale; 1996; 22(6):461-7. PubMed ID: 10901839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
    Lydiard RB; Ballenger JC; Rickels K
    J Clin Psychiatry; 1997; 58 Suppl 11():11-8. PubMed ID: 9363043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled discontinuation of benzodiazepine treatment for patients with panic disorder.
    Noyes R; Garvey MJ; Cook B; Suelzer M
    Am J Psychiatry; 1991 Apr; 148(4):517-23. PubMed ID: 2006699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.